PRACTICAL DIAGNOSTIC LABORATORY TESTS FOR COVID-19 IN THE EMERGENCY DEPARTMENT
DOI:
https://doi.org/10.46827/ejphs.v5i1.117Keywords:
COVID-19, diagnostic tests, emergency departmentAbstract
COVID-19 is an infectious disease caused by the SARS-Cov-2, and it was first reported in Wuhan province of China. RT-PCR test for viral nucleic acids in the diagnosis of COVID-19 is the gold standard method. However, when the number of patients admitted to the emergency department is too high, it may take a long time to result in the PCR test. In areas where suspicious cases are followed in isolation, possible PCR negative cases are also at risk. In the study, the data of patients who were admitted to the emergency department of Samsun Training and Research Hospital with the suspicion of COVID-19 in the years 2020-2021 were analyzed retrospectively. Laboratory and chest CT images were examined through the hospital's information processing system. The C-Reactive Protein (CRP), D-dimer, White Blood Cell (WBC) count, and Eosinophil count of the patients admitted as suspicious cases were evaluated. Chest CT images were evaluated according to the CO-RADS classification. A statistically significant difference was found between PCR positive and negative patients in terms of eosinophil count, CRP, d-dimer and CO-RADS classification. In our study, tests were evaluated at the stage of making a faster and more accurate diagnosis. In addition, the patient group included in our study is a specific group of patients who did not receive any medical treatment that could affect the results of the examination. As a result, when our study and previous studies are evaluated, CRP, d-dimer, eosinophil count and computerized tomography are the tests that can be used in the diagnosis of COVID-19. And examinations can be used in units where rapid diagnosis is required, such as emergency services.
References
An, J. Y., Unsdorfer, K. M., & Weinreb, J. C. (2019). BI-RADS, C-RADS, CAD-RADS, LI-RADS, Lung-RADS, NI-RADS, O-RADS, PI-RADS, TI-RADS: Reporting and Data Systems. Radiographics, 39(5), 1435-1436.
Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D. Y., Chen, L., & Wang, M. (2020). Presumed asymptomatic carrier transmission of COVID-19. Jama, 323(14), 1406-1407.
Chen, G., Wu, D. I., Guo, W., Cao, Y., Huang, D., Wang, H., & Ning, Q. (2020). Clinical and immunological features of severe and moderate coronavirus disease 2019. The Journal of clinical investigation, 130(5), 2620-2629.
Fahmi, I. (2019). World Health Organization coronavirus disease 2019 (Covid-19) situation report. DroneEmprit.
Gao, Y., Li, T., Han, M., Li, X., Wu, D., Xu, Y., & Wang, L. (2020). Diagnostic utility of clinical laboratory data determinations for patients with severe COVID‐19. Journal of medical virology, 92(7), 791-796.
Li, Y. Y., Wang, W. N., Lei, Y., Zhang, B., Yang, J., Hu, J. W., & Lu, Q. F. (2020). Comparison of the clinical characteristics between RNA positive and negative patients clinically diagnosed with coronavirus disease 2019. Zhonghua Jie He He Hu Xi Za Zhi, 427-430.
McInnes, M. D., Moher, D., Thombs, B. D., McGrath, T. A., Bossuyt, P. M., Clifford, T., ... & Willis, B. H. (2018). Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. Jama, 319(4), 388-396
Qian, G. Q., Yang, N. B., Ding, F., Ma, A. H. Y., Wang, Z. Y., Shen, Y. F., & Chen, X. M. (2020). Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series. QJM: An International Journal of Medicine, 113(7), 474-481.
World Health Organization. (2020). Laboratory testing for coronavirus disease 2019 ( COVID-19) in suspected human cases: interim guidance, 2 March 2020 (No. WHO/COVID-19/laboratory/2020.4). World Health Organization.
Zhang, B., Zhou, X., Zhu, C., Song, Y., Feng, F., Qiu, Y., & Wang, J. (2020). Immune phenotyping based on the neutrophil-to-lymphocyte ratio and IgG level predicts disease severity and outcome for patients with COVID-19. Frontiers in molecular biosciences, 7, 157.
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
